Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy.

ABSTRACT:

Purpose

To report the 3-year outcomes of surgical bleb revision (SBR) with mitomycin C (MMC) for early scarring bleb after trabeculectomy (TLE).

Study design

Retrospective observational study.

Methods

We included glaucoma patients aged ≧ 18 who underwent SBR with MMC within 6 months of their first TLE at Kobe University Hospital and were followed for at least 6 months. The primary outcome measure was the three-year success rate of SBR. We defined surgical success as: intraocular pressure (IOP) reduction ≧ 20% from baseline and 5 ≦ IOP ≦ 18 mmHg. Failure was defined when the IOP deviated from the criteria, when the eye required additional glaucoma surgery, and when the eye lost light perception. Complete success (CS) was success without glaucoma medications and qualifi

SUBMITTER: Caraher-Masuda R 

PROVIDER: S-EPMC11821706 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature